Blood Podcast cover image

Specific CD8+ T cell clones in ITP, Refining DLBCL prognosis with the “dark-zone signature”, and rethinking the regenerative role of HSCs in acute hematopoietic emergencies

Blood Podcast

00:00

The Role of Cell of Origin in the Treatment of Diffuse Large B-Cell Lymphoma

Diffuse Large B-Cell Lymphoma is an aggressive but curable disease. But for those who relapse or are refractory to frontline treatment, outcomes are poor. The majority of DL-BCL can be dichotomized into the German National Center B-Cell-Like Subgroup (GCB) GCB patients have a three-year rate of progression-free survival that's 15 to 25 percent higher than ABC DL-BCl.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app